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Abstract: Three major flavonoid chamomile components (quercetin, apigenin-7-O-glucoside and rutin) were subjected to 
oxidative metabolism by cytochrome P-450 of rat liver microsomal preparations. Changes over time in their respective 
concentrations were followed using reversed-phase HPLC with UV detection. No clean-up had to be applied as only the 
specific flavonoid had to be separated from the background components originating from the rat liver microsome. 
Neither the concentration of apigenin-7-O-glucoside nor that of the diglycoside rutin decreased during one hour of 
exposure to rat microsomal treatment. In contrast, the concentration of quercetin, a lipophilic aglycon, decreased. 
Our analytical HPLC results complement the in silico calculated lipophilicity (logP) of these compounds; the relatively 
high lipophilicity of quercetin appears to predispose it to oxidative metabolism in order to decrease its fat solubility. In 
contrast the much less lipophilic compounds apigenin-7-O-glucoside and rutin were resistant in vitro to microsomal 
treatment. 
Keywords: Microsomal treatment, cytochrome P-450 dependent oxidation, HPLC, quercetin, apigenin-7-O-glucoside, rutin. 
INTRODUCTION 
 Chamomile is one of the oldest and best known 
favourites amongst medicinal herbs and its position as a 
therapeutical plant with multiple uses is well established. 
The positive effects derived from chamomile use are related 
to the presence of its numerous flavonoid constituents. 
Regarding their core structure many of these constituents are 
either flavone- (apigenin, luteolin) or flavonol- derivatives 
(quercetin, patuletin, isorhamnetin) [1]. They appear in 
various forms such as aglyca, mono- and diglycosides, 
and/or acyl-derivatives [2]. 
 Some of these constituents have been directly associated 
with specific therapeutic effects; luteolin and the quercetin 
aglyca for instance have demonstrated protective and delaying 
effects on the development of diabetic complications [3]. 
 Furthermore apigenin and its -7-O-glucoside derivative 
are among the most important therapeutic flavonoids; their 
spasmolytic and antiphlogistic effects are especially 
prominent [4], in addition to anti proliferative and apoptotic 
effects in various human cancer cell lines [5]. 
 
 
*Address correspondence to this author at the Department of 
Pharmacodynamics, Semmelweis University, 1089 Budapest, Nagyvárad tér 
4, Hungary; E-mail: drtekes@gmail.com 
 The presence of apigenin in chamomile is however a 
matter of some debate as its presence has not been proved 
unequivocally. Carle et al. [6] and Schreiber et al. [7] 
compared extracts derived from freshly collected wild plants 
with those obtained from greenhouse plants. They concluded 
that apigenin is not originally present in fresh chamomile, 
but the result of secondary enzymatic processes. This would 
explain the great differences in the reported ratios of 
apigenin and apigenin-7-O-glycoside in the literature, 
differences which might also be due to different harvesting 
methods and storage conditions used. Rep?ak and Martonfi 
[8] observed that the content of apigenin aglyca in various 
parts of the flower increases by polyploidization. In di- and 
tetraploid samples the amount of apigenin aglyca increased 
by about 15 %. According to both the European and 
Hungarian Pharmacopoeias [9] the content of apigenin-7-O-
glucoside in the Matricaria flower should be at least 0,25 %. 
This content is measured by HPLC. The HPLC method is 
suitable for the determination of other flavones too, 
irrespective of their state of glycosylation and/or acylation 
[9-15]. 
 Our aim was to establish whether any of the major 
matricaria components [quercetin, apigenin-7-O-glucoside 
and rutin] is subjected to hepatic oxidative microsomal 
metabolism. 
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Table 1. Name, Chemical Structure, Molecular Size and Composition Calculated Value of Lipophilicity (logP) and Total Polar 
Surface Area (TPSA, in Angström) of Certain Flavonoids Derived from Chamomile 
 
# Name Structure MW logP TPSA 
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O
O
O
CH3
OH
OH OH
OH
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O
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HO
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-0.01 166.14 
03 Quercetin 
OHO
OH
OH
O
OH
OH
 
C15H10O7 
302.25 
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(Table 1) contd….. 
# Name Structure MW logP TPSA 
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1.87 125.68 
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EXPERIMENTAL 
 Materials: HPLC grade acetonitrile, methanol and 
trifluoroacetic acid were purchased from Merck (Darmstadt, 
Germany). Water was double-distilled and deionized. Rutin, 
apigenin-7-O-glucoside and quercetin were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). The chemical 
structures of rutin, apigenin-7-O-glucoside and quercetin are 
shown in Table 1. The Zorbax RX-C-18 column and 
precolumn were purchased from Kromat Kft. (Budapest, 
Hungary). 
 Microsomal Preparation: Quercetin, apigenin-7-O-
glucoside and rutin (25 μM, each) were incubated separately 
for 0, 15, 30, 45 and 60 minutes with rat liver microsome 
(Gedeon Richter Plc., Budapest, Hungary, Lot no. 081022, 
0.5 mg mL-1) in 4 mL incubation medium also consisting of 
Tris-HCl buffer (0.12 mM, pH 7.4 at 37°C), MgCl2 (5 mM), 
sodium phosphate (6.25 mM), D-glucose-6-phosphate (5 
mM), D-glucose 6-phosphate dehydrogenase (1 UmL-1), and 
the reduced form of nicotinamide adenine dinucleotide 
phosphate (NADPH, 0.5 mM). Parallel experiments were 
carried out using each substance (quercetin, apigenin-7-O-
glucoside, rutin) in the buffered medium but without any D-
glucose-6-phosphate, D-glucose 6-phosphate dehydrogenase 
and the reduced form of nicotinamide adenine dinucleotide 
phosphate. A control experiment that subjected the entire 
mixture to microsomal treatment (rat liver microsome, in the 
solution of Tris-HCl buffer at pH 7.4, MgCl2, sodium 
phosphate, D-glucose-6-phosphate, D-glucose 6-phosphate 
dehydrogenase, and the reduced form of nicotinamide 
adenine dinucleotide phosphate) but without any substrate to 
be metabolized was also performed. Microsomal treatment 
was done using a rotating, thermostat-regulated water bath at 
37°C. Incubation with microsomal preparation was 
terminated after 0, 15, 30 and 60 min respectively, by adding 
a 4-fold excess of methanol. Each experiment was performed 
in duplicate. Incubated samples were placed at -20 oC for 10 
minutes, and centrifuged using 2500 x g at 4 oC (Sigma 
Laborzentrifugen, Osterode am Harz, Germany) and finally 
stored at -80 oC before their reversed-phase HPLC 
measurement. 
 Chromatography: A JASCO made HPLC system was 
used that contained a solvent delivery system (PU 1580 
Pump), degasser (DG-2080-54), an autoinjector (AS-2057 
Plus), and a UV detector (UV-1575). Elution of rutin, 
apigenin-7-O-glucoside and quercetin was monitored at 257 
nm. 
 The samples were not subjected to any clean-up. Fifty μL 
of the samples were injected. The separation was done on a 
250 mm x 4.6 mm I.D., 5-μm particle size Zorbax RX-C-18 
column protected by a 12.5 mm x 4.6 mm, I.D. precolumn 
containing the same packing material. The mobile phases 
were acetonitrile—water 40:60, 35:65, 30:70, 25:75, 20:80, 
15:85 and 10:90, and each mobile phase contained 0.1% of 
trifluoroacetic acid (TFA). The mobile phase flow rate was 1 
mL min-1, the separations were done at ambient temperature 
(24°C ± 1°C). Chromatograms were electronically stored and 
evaluated by the use of Borwin 1.50 chromatography 
software (JMBS, Le Fontanil, France). 
 Calibration: Calibrations of the substances were done 
covering 0.5 μg mL-1 through 20 μg mL-1 range for quercetin, 
apigenin-7-O-glucoside and rutin. 
 Lipophilicity Calculations: The logP value, and the 
total polar surface area (TPSA) were calculated using the 
Pallas program of CompuDrug [16,17]. 
RESULTS 
 The physico-chemical parameters of several chamomile 
flavonoids belonging to three major groups [aglycons 
(flavonoid compounds without any substituting sugar), 
monoglycosylated and diglycosylated] were calculated using 
the Pallas program. Chemical structures, molecular 
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Fig. (1). The elution of quercetin, apigenin-7-O-glucoside and rutin are characterized by their k’ values when using various compositions of 
the mobile phases. 
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composition, molecular size, logP and total polar surface 
area (TPSA in Angström) are given in Table 1. Flavonoid 
aglycons were rather lipophilic with a logP value higher than 
1.5. 
 The mobile phase composition for HPLC of quercetin, 
apigenin-7-O-glucoside and rutin was optimized to avoid 
any interference with the background signal of the 
microsomal incubation medium. Different ratios of the 
organic modifier and water in the mobile phases were used, 
such as acetonitrile—water 50:50, 45:55, 40:60, 35:65, 
30:70, 25:75, 20:80, 15:85, 10:90 (Fig. 1). Using the 
optimum mobile phase compositions, the peaks of quercetin, 
apigenin-7-O-glucoside and rutin eluted at 7.10, 7.72 and 
7.73 minutes with the ratio of acetonitrile and water (30:70) 
for separation of qurcetin, apigenin-7-O-glucoside (20:80) 
and rutin (15:85), respectively. (Fig 2, from left to right). 
 No interference of any one of the flavonoid compound 
peaks with those from the microsomal medium was found. 
Fig. (3) shows that calibration for all substances produced a 
straight line characterized by their respective parameters,  
a, y0 and R
2 (from the equation of the straight line: y = ax + y0), as 
shown in Table 2. 
 Molecular size (MW), lipophilicity (logP) and total polar 
surface area (TPSA) of several flavonoids were calculated 
using the Pallas Program of CompuDrug Inc. These values 
are given in Table 1. 
CONCLUSIONS 
 Chamomile [the dried flower heads of Matricaria recutita 
L. (Chamomilla recutita [L.] Reuschert] has been used for 
centuries as a home remedy; its therapeutic value is well 
established as documented by the inclusion in numerous 
Pharmacopoeias. 
 In traditional medicine the plant is mostly used as 
chamomile tea, which is administered p.o. for alleviation of 
gastro-intestinal complaints [18]. Externally chamomile is 
applied on skin and/or mucous membranes at sites of minor 
inflammation, including the oral cavity and the gums 
(mouthwashes), the respiratory tract (inhalations), and the 
anal and genital areas (baths, ointments) [19,20]. 
 The main constituents of chamomile are the essential oil 
and the flavone derivatives [21-23]. 
 In vitro liver microsomal treatment of organic 
compounds serves as a model for the first pass effect of the 
Fig. (2). Typical chromatograms of the microsomal medium spiked with the appropriate amount of quercetin, apigenin-7-O-glucoside and 
rutin in panels a, b and c respectively. 
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liver in a living animal. Information may be obtained both on 
the putative fate of the compound in the body, and also the 
preferred way of administration. Liver microsomes generally 
metabolize xenobiotics (foreign compounds ingested) using 
oxidative metabolism via the cytochrome P-450 system. The 
lipophilicity of xenobiotics decreased via these reactions. 
 
 Fig. (4) compares the relative changes of the 
concentrations of quercetin, apigenin-7-O-glucoside and 
rutin during microsomal treatment. While the concentration 
of rutin and that of apigenin-7-O-glucoside remain 
unchanged, that of quercetin decreases. 
 The most lipophilic flavonoid, the aglycon quercetin 
undergoes cytochrome P-450-dependent microsomal 
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Fig. (3). Calibration curve for quercetin, apigenin-7-O-glucoside and rutin using the adequate mobile phase. 
Table 2. Characteristics of the Calibration Lines (y = ax + y0) of RP-HPLC Quantitative Determination of Quercetin, Apigenin-7-
O-Glucoside and Rutin 
 
Compound a (Slope) y0 R
2
 
Quercetin (03) 51077 3701 0.9993 
Apigenin-7-O-glucoside (02) 66236 8101 0.9991 
Rutin (01) 71362 2246 0.9995 
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Fig. (4). Concentration of quercetin, apigenin-7-glucoside and rutin through the microsomal treatment at 0, 15, 30 and 60 min of the 
treatment. 
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metabolism, while the two less lipophilic compounds 
examined (apigenin-7-O-glucoside and rutin) were resistant 
to the effect of rat liver microsome (Fig. 4). 
REFERENCES 
[1] Carle, R.; Isaac, Q. Fortschritte in der Kamillenforschung in den 
Jahren 1974 bis 1984. Dtsch. Apoth. Ztg., 1985, 125(Suppl 1), 2-8. 
[2] ?vehliková, V.; Bennett, R.N.; Mellon, F.A.; Needs, P.W.; 
Piacente, S.; Kroon, P.A.; Bao, Z. Isolation, identification and 
stability of acylated derivatives of apigenin 7-O-glucoside from 
chamomile (Chamomilla recutita [L.] Rauschert). Phytochemistry, 
2004, 65, 2323-2332. 
[3] Kato, A.; Minoshima, Y.; Yamamoto, J.; Adachi, I.; Watson, A.A.; 
Nash, R.J. Protective effects of dietary chamomile tea on diabetic 
complications. J. Agricult. Food Chem., 2008, 56, 8206-8211.  
[4] Petri, G. Gyógynövények és készítményeik a terápiában (Medicinal 
Plants and their Products in Therapy, in Hungarian), Galenus 
Publisher: Budapest, 2006.  
[5] Srivastava, J.K.; Gupta, S. Anti proliferative and apoptotic effects 
of chamomile extract in various human cancer cells. J. Agricult 
Food Chem., 2007, 55, 9470-9478. 
[6] Carle, R.; Dölle, B.; Müller, W.; Baummeister, U. Thermospray 
liquid-chromatography mass-spectrometry (tsp lc/ms) - analysis of 
acetylated apigenin-7-glucosides from chamomilla-recutita. 
Pharmazie, 1993, 48, 304-306. 
[7] Schreiber, A.; Carle, R.; Reinhard, E. On the accumulation of 
apigenin in  chamomile flowers. Planta Med., 1991, 56, 179-181. 
[8] Rep?ak, M.; Martonfi, P. The variability pattern of apigenin 
glucosides in chamomilla-recutita diploid and tetraploid cultivars. 
Pharmazie, 1995, 50, 696-699. 
[9]  Pharmacopoea Hungarica, Ed. VIII. Tomus II., Medicina, 
Budapest, 2004, pp. 1944-1946, 2203-5.  
[10] Carle, R. In Hagers Handbuch der Pharmazeutischen Praxis, 5th 
ed., Hänsel, R.; Keller, K.; Rimpler, H.; Schneider, G., Eds.; 
Springer: Berlin, 1992, 4, pp. 817-831. 
[11] Kakasy, A.; Marczal, G.; Héthelyi, É.; Lemberkovics, É. 
Dracocephalum fajok mikromorfológiai és fitokémiai jellemzése 
(Micromorphology and phytochemistry of certain Dracocephalum 
species, in Hungarian). Botanikai Közlemények, 2004, 91, 140. 
[12] Papp, I.; Apáti, P.; Andrasek, V.; Blázovics, A.; Balázs, A.; 
Kursinszki, L.; Kite, G.C.; Houghton, P.J.; Kéry, Á. LC-MS 
analysis of antioxidant plant phenoloids. Chromatographia, 2004, 
60, S93-S100. 
[13] Kakasy, A.; F?zfai, Z.; Kursinszki, L.; Molnár-Perl, I.; Lemberkovics, 
É. Analysis of non-volatile constituents in Dracocephalum species by 
HPLC and GC-MS. Chromatographia, 2006, 63, S17-S22. 
[14] Weber, B.; Herrmann, M.; Hartmann, B.; Joppe, H.; Schmidt, C.O.; 
Bertram, H.J. HPLC/MS and HPLC/NMR as hyphenated 
techniques for accelerated characterization of the main constituents 
in Chamomile (Chamomilla recutita [L.] Rauschert). Eur. Food 
Res. Technol., 2008, 226, 755-760. 
[15] Sz?ke, É.; Kéry, Á.; Lemberkovics, É. Schweiz Pharmacognosy. 
Pharmacobotanical and Phytochemical Investigations of Plant 
Drugs. Semmelweis Kiadó, Budapest, 2009, (in press). 
[16] Pallas Program: www.compudrug.com 
[17] Molnár, L.; Keser?, G.M.; Papp, Á.; Gulyás, Z.; Darvas, F. A 
neural network based classification scheme for cytotoxicity 
predictions: validation on 30,000 compounds. Bioorg. Med. Chem. 
Lett., 2006, 16, 81037-81039.  
[18] Franke, R.; Schilcher, H. Chamomile Industrial Profiles, CRC 
Press: Boca Raton, 2005. 
[19] Carle, R.; Isaac, O. Die Kamille – Wirkung und Wirksamkeit. Z. 
Phytotherapie, 1987, 8, 67. 
[20] Förster, C.F.; Süssmann, H.E.; Patzelt-Wenczler, R. Schweiz. 
Rundschau Med., 1996, 85, 1476. 
[21] Schilcher, H. Die Kamilla – Handbuch für Ärzte, Apotheker und 
anderen Naturwissenschaftler, Wiss. Verlagsges, Stuttgart, 
Germany, 1987, p. 152.  
[22] Sz?ke, É.; Máday, E.; Tyihák, E.; Kuzovkina, I.N.; Lemberkovics, 
É. New terpenoids in cultivated and wild chamomile (in vivo and in 
vitro). J. Chromatogr. B, 2004, 800, 231-238. 
[23] Shikov, A.N.; Laakso, I.; Pozharitskaya, O.N.; Darman, H.J.D.; 
Makarov, V.G.; Tikhonov, V.P.; Hiltunen, R. Identification of 
spiroketal polyacetylenes as the main components of an oil extract 
of chamomile (Chamomilla recutita L. Rausch.) flowers. Planta 
Med., 2006, 72, 1026. 
 
 
Received: March 23, 2009 Revised: May 8, 2009 Accepted: May 17, 2009 
 
© A.A. El Maghraby; Licensee Bentham Open. 
 
This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-
nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. 
 
 
 
 
